Skip to main content
. 2020 Jul 1;12(7):1754. doi: 10.3390/cancers12071754

Figure 4.

Figure 4

Association of circulating RAS mutation allele fraction (MAF) with primary tumor and metastases location. (A) circulating MAF levels in patients with tumor located in the body-tail or the head of the pancreas; (B) circulating MAF levels in patients with metastatic lesions in the liver or elsewhere (* p < 0.05, ** p < 0.01).